Biotechnology News

Tue, 2013-08-06 14:02

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock, offered at a price to the public of $4.40 per...

Tue, 2013-08-06 14:02

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories reported second-quarter 2013 financial results

Tue, 2013-08-06 14:02

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead to Report Fiscal 2013 Third Quarter Financial Results with Conference Call Scheduled for Wednesday, August 7, 2013

Tue, 2013-08-06 14:02

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics today announced results for its fiscal 2013 third quarter.

Tue, 2013-08-06 14:02

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the second quarter and six months ended June 30, 2013. The company also highlighted ADCETRIS (brentuximab vedotin) commercialization and...

Tue, 2013-08-06 14:02

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended June 30,...

Tue, 2013-08-06 14:02

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker's Q2 2013 Earnings Release

Tue, 2013-08-06 14:02

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ: AFFX) today reported its operating results for the second quarter of 2013. Results for the three months ended June 30, 2013: Total revenue was $79.5 million, which included revenue...

Tue, 2013-08-06 14:02

HOUSTON--(BUSINESS WIRE)--Siemens Healthcare Diagnostics further expanded its industry-leading clinical laboratory automation portfolio¹ by unveiling VersaCell® X3 Solution² at the 2013 AACC and ASCLS Annual Meeting and Clinical Lab Expo in...

Tue, 2013-08-06 14:02

MINNEAPOLIS--(BUSINESS WIRE)--Advanced Circulatory Closes $2 Million Bridge Financing

Tue, 2013-08-06 14:02

HOUSTON--(BUSINESS WIRE)--Siemens Healthcare Diagnostics is showcasing its latest innovations that unite clinical and workflow excellence to help laboratories “Test smarter. Run faster.” at the 2013 AACC and ASCLS Annual Meeting and Clinical Lab...

Tue, 2013-08-06 14:02

ALAMEDA, Calif.--(BUSINESS WIRE)--Singulex, Inc., first to commercialize Single Molecule Counting (SMC) technology and committed to improving patient care and enabling the reduction of healthcare costs by providing high-value, advanced tests and...

Tue, 2013-08-06 14:02

WASHINGTON--(BUSINESS WIRE)--As INEOS Bio announces start of commercial cellulosic ethanol production in Vero Beach, Florida, BIO says this is a reason to continue the Renewable Fuel Standard without changes

Tue, 2013-08-06 14:02

MADISON, Wis.--(BUSINESS WIRE)--Stratatech Corp., a leader in regenerative medicine, announced today that it has been awarded a contract valued at up to $47.2 million by the U.S. Department of Health and Human Service’s Biomedical Advanced...

Tue, 2013-08-06 14:02

INDIANAPOLIS--(BUSINESS WIRE)--Emphymab Biotech, a seed stage company developing disease-modifying therapeutics for chronic obstructive pulmonary disease (COPD), wins "Best Seed Pitch" at 2013 Innovation Showcase.

Tue, 2013-08-06 14:02

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--In June 2013, Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac...

Tue, 2013-08-06 14:02

IRVINE, Calif.--(BUSINESS WIRE)--California Stem Cell, Inc. has announced the completion of an internal study demonstrating that the company’s proprietary immunotherapy manufacturing process can be applied to multiple cancer types.

Tue, 2013-08-06 14:02

UPPSALA, Sweden & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm and Olink Bioscience have teamed up to enable interrogation of 96 samples across 92 proteins in a single run from one microliter of sample in less than a day.

Tue, 2013-08-06 14:02

MEDFORD, Mass.--(BUSINESS WIRE)--Hepregen Corporation announced today the appointment of Martin J. Joyce as Vice President of Finance and Administration and Chief Financial Officer.

Tue, 2013-08-06 14:02

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended June 30, 2013. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share,...

Tue, 2013-08-06 14:02

SPENCER, Mass.--(BUSINESS WIRE)--FLEXcon announced the launch of FLEXcon® MedFLEX™, a line of label substrates that meets all performance criteria required by the Food and Drug Administration’s proposed unique device identifier rule.

Tue, 2013-08-06 14:02

TAMPA, Fla.--(BUSINESS WIRE)--BioFlorida, Florida’s life sciences association, will host the state’s life science industry during the 16th Annual Life Sciences Conference, Sept. 15–17, 2013 at the Tampa Marriott Waterside.

Tue, 2013-08-06 14:02

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics has entered into a $15 million three-part agreement with Bimini Technologies and its affiliates, Puregraft Technologies and Kerastem Technologies.

Tue, 2013-08-06 14:02

--(BUSINESS WIRE)--CoolSculpting exhibiting at the American Academy of Dermatology (AAD) in New York, July 31-August 4, 2013.

Tue, 2013-08-06 14:02

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US and Non-UK Media Boehringer Ingelheim (BI) and Eli Lilly and Company today announced enrollment of the first patient into a cardiovascular and renal outcomes trial for linagliptin (Trajenta®). The...

Tue, 2013-08-06 14:02

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals Inc., a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, today announced that it has decided not to pursue its initial public offering (IPO). The...

Tue, 2013-08-06 14:02

MADISON, Wis.--(BUSINESS WIRE)--Mirus Announces Transfection Advance: TransIT-X2™ Dynamic Delivery System; New High Performance Broad Spectrum Transfection System, Capable of Delivering DNA and siRNA

Tue, 2013-08-06 14:02

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Awarded Collaborative NIH Grant to Accelerate Development of New Treatment for Fragile X Syndrome

Tue, 2013-08-06 14:02

SAN FRANCISCO--(BUSINESS WIRE)--AstraZeneca and FibroGen today announced that they have entered into a strategic collaboration to develop and commercialize FG-4592, a first-in-class oral compound in late stage development for the treatment of...

Tue, 2013-08-06 14:02

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) and JW Holdings today announced that they have entered into an exclusive distribution and license agreement for parenteral nutritional products containing a novel formulation...

Tue, 2013-08-06 14:02

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its board of directors declared a third quarter dividend of $0.25 per common share. This dividend amount is equal to the...

Tue, 2013-08-06 14:02

THE WOODLANDS, Texas--(BUSINESS WIRE)--Pernix To Report Second Quarter 2013 Financial Results

Tue, 2013-08-06 14:02

MENLO PARK, Calif.--(BUSINESS WIRE)--MedtechWomen today announced that registration is open for MedtechVision 2013, the third annual conference designed by and for women on the forefront of medical innovation. The conference will be held...

Tue, 2013-08-06 14:02

LEXINGTON, Mass. & SAN DIEGO--(BUSINESS WIRE)--Cubist Pharmaceuticals to Acquire Trius Therapeutics

Tue, 2013-08-06 14:02

LEXINGTON, Mass. & JERSEY CITY, N.J.--(BUSINESS WIRE)--Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals

Tue, 2013-08-06 14:02

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc., (NASDAQ:BCRX) today announced that it is offering to sell, subject to market and other conditions, shares of its common stock pursuant to an effective shelf...

Tue, 2013-08-06 14:02

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) will host an Investor Day for institutional investors and research analysts on Monday August 5, 2013 from approximately 12:00 p.m. to 3:30 p.m. ET in New York, New York. The...

Tue, 2013-08-06 14:02

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) today announced financial results for the second quarter ended June 30, 2013. "Successful completion of the INTERCEPT platelet and plasma U.S. PMA submissions in November 2013 and...

Fri, 2013-07-26 11:45

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex Confirms Takeda Receives Positive CHMP Opinion for VIPIDIA™ (alogliptin) and Fixed-Dose Combinations VIPDOMET™ (alogliptin and metformin) and INCRESYNC™ (alogliptin and pioglitazone)

Fri, 2013-07-26 11:45

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD issued the following statement regarding the conclusion of the EMA’s CHMP review of GLP-1, or incretin-based, therapies, including sitagliptin.

Fri, 2013-07-26 11:45

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck issued the following statement regarding the conclusion of the EMA’s CHMP review of GLP-1, or incretin-based, therapies, including sitagliptin.

Fri, 2013-07-26 11:45

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. announced today the release of LifeMap Discovery™ version 1.2 (discovery.lifemapsc.com). LifeMap Discovery™ is a state-of-the-art roadmap of embryonic development and stem cell biology. The...

Fri, 2013-07-26 11:45

IRVINE, Calif.--(BUSINESS WIRE)--California Stem Cell, Inc. (“CSC”) announced today the submission of a Phase III protocol to the U.S. Food and Drug Administration (“FDA”) for a randomized, double-blind study in metastatic melanoma.

Fri, 2013-07-26 11:45

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner GlaxoSmithKline (NYSE: GSK) announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a positive...

Fri, 2013-07-26 11:45

GENEVA--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for delamanid for the treatment of...

Fri, 2013-07-26 11:45

LEBANON, N.H.--(BUSINESS WIRE)--Adimab, LLC, a leader in the discovery of fully human monoclonal and bispecific antibodies, expanded collaboration its with Biogen Idec for the discovery of antibody based therapeutics.

Fri, 2013-07-26 11:45

LOS ANGELES--(BUSINESS WIRE)--Meditope Biosciences, Inc., a biotechnology company developing antibody-based cancer products, today announced it has raised $3.6 million in Series A funding from angel investors to advance its proprietary monoclonal...

Fri, 2013-07-26 11:45

LEBANON, N.H.--(BUSINESS WIRE)--Adimab, LLC, a leader in the discovery of fully human monoclonal and bispecific antibodies, today announced its first platform technology transfer and license agreement with GlaxoSmithKline (GSK).

Fri, 2013-07-26 11:45

SALT LAKE CITY--(BUSINESS WIRE)--Lipocine, Inc. (OTCBB:MBARD), a specialty pharmaceutical company, announced today that it has entered into securities purchase agreements with gross proceeds of $38.0 million for the issuance and sale of...